A Review on various promising antivirals for management of COVID 19 & Comparison of Regimens of Antivirals in various Treatment guidelines for Management of Covid-19 across the world

Authors

  • Muhammed Rashid A.K Inpatient Pharmacist, Sheikh Shakbouth Medical City (SSMC) Hospital, Abu Dhabi, United Arab Emirates
  • Jimcy Mathew Inpatient Pharmacist, Danat Al Emarat Hospital, Abu Dhabi, United Arab Emirates

Keywords:

COVID-19 Antivirals, SARS-COV2 Antivirals, Antivirals used in management of COVID-19, Covid-19 treatment guidelines

Abstract

An acute respiratory disease, caused by a novel coronavirus SARS-CoV-2 (COVID-19) has spread from Wuhan city of China and received worldwide attention. On 30 January 2020, World Health Organization (WHO) officially declared the COVID-19 as a PANDEMIC. The emergence of SARS-CoV-2, since the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 and Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, marked the third introduction of a highly pathogenic and large-scale epidemic coronavirus into the human population in the twenty-first century. In this article, we are discussing about various promising antivirals showing potential effect in COVID 19 management worldwide.

Downloads

Published

2020-12-22

How to Cite

Muhammed Rashid A.K, & Jimcy Mathew. (2020). A Review on various promising antivirals for management of COVID 19 & Comparison of Regimens of Antivirals in various Treatment guidelines for Management of Covid-19 across the world. World Journal of Pharmaceutical Sciences, 9(1), 46–59. Retrieved from https://wjpsonline.com/index.php/wjps/article/view/79

Issue

Section

Review Article